Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer-Reference-Cited by-同舟云学术

Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer

Published:2002-01 Issue:1 Volume:13 Page:92-94
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Punt C.J.A.,Blanke C.D.,Zhang J.,Hammershaimb L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/1/92/19479841/92.pdf

Reference3 articles.

1. Biomodulation of 5-fluorouracil with antifolates;Bertino;Semin Oncol,1997

2. Trimetrexate as biochemical modulator of 5-fluorourail/leucovorin in advanced colorectal cancer: final results of a randomised European study;Punt;Ann Oncol,2002

3. A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer;Blanke;Ann Oncol,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S9511;American Journal of Clinical Oncology;2010-04

2. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates;Investigational New Drugs;2006-01

3. Monitoring fluoropyrimidine metabolism in solid tumors with in vivo 19F magnetic resonance spectroscopy;Critical Reviews in Oncology/Hematology;2005-12

4. A Phase I/II Study of Trimetrexate and Capecitabine in Patients With Advanced Refractory Colorectal Cancer;American Journal of Clinical Oncology;2005-10

5. New options and old dilemmas in the treatment of patients with advanced colorectal cancer;Annals of Oncology;2004-10